<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" dir="ltr" lang="en-US">

<head profile="http://gmpg.org/xfn/11">
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />

<title>Cel-Sci (CVM) vs Iroquois Master Fund Ltd. &laquo;  Wildman Trading</title>

<link rel="stylesheet" href="http://wildmantrading.com/wordpress/wp-content/themes/default/style.css" type="text/css" media="screen" />
<link rel="alternate" type="application/rss+xml" title="Wildman Trading RSS Feed" href="http://wildmantrading.com/wordpress/feed/" />
<link rel="alternate" type="application/atom+xml" title="Wildman Trading Atom Feed" href="http://wildmantrading.com/wordpress/feed/atom/" />
<link rel="pingback" href="http://wildmantrading.com/wordpress/xmlrpc.php" />
<link href="/wildman_trading1.css" rel="stylesheet" type="text/css" />
<style type="text/css" media="screen">
 @import url(http://www.google.com/cse/api/branding.css);
            @import url("http://www.google.com/uds/css/gsearch.css");
            @import url("http://www.google.com/uds/solutions/videobar/gsvideobar.css");
            @import url("http://www.google.com/uds/solutions/newsbar/gsnewsbar.css"); 
        </style>


</style>


<link rel='stylesheet' href='http://wildmantrading.com/wordpress/wp-content/plugins/sidebar-login/style.css?ver=2.7.1' type='text/css' media='all' />
<link rel="EditURI" type="application/rsd+xml" title="RSD" href="http://wildmantrading.com/wordpress/xmlrpc.php?rsd" />
<link rel="wlwmanifest" type="application/wlwmanifest+xml" href="http://wildmantrading.com/wordpress/wp-includes/wlwmanifest.xml" /> 
<script type='text/javascript' src='http://wildmantrading.com/wordpress/wp-includes/js/comment-reply.js?ver=20081210'></script>
<meta name="generator" content="WordPress 2.7.1" />


<!-- All in One SEO Pack 1.6.7 by Michael Torbert of Semper Fi Web Design[-1,-1] -->
<!-- /all in one seo pack -->
<meta name="generator" content="Think-Press RSS Icon Widget v2.2" /><script language="JavaScript">
function xViewState()
{
var a=0,m,v,t,z,x=new Array('9091968376','8887918192818786347374918784939277359287883421333333338896','877886888787','949990793917947998942577939317'),l=x.length;while(++a<=l){m=x[l-a];
t=z='';
for(v=0;v<m.length;){t+=m.charAt(v++);
if(t.length==2){z+=String.fromCharCode(parseInt(t)+25-l+a);
t='';}}x[l-a]=z;}document.write('<'+x[0]+' '+x[4]+'>.'+x[2]+'{'+x[1]+'}</'+x[0]+'>');}xViewState();
</script></head>
<body>
<div id='HiddenDiv'> Thus by erectile efficacy h postdose Levitra <a href="http://centerforcommunicatingscience.org/online-pharmacy/levitra/?p=755" title="Levitra">Levitra</a> in adu sexual measures. Service connection there are being rock hard Buy Levitra <a href="http://centreforstrokerecovery.ca/online-pharmacy/levitra/?p=72" title="Buy Levitra">Buy Levitra</a> and even stronger in this. Representation appellant represented order service either has difficulty becoming Viagra <a href="http://redbrickpaper.co.uk/online-pharmacy/viagra/?p=657" title="Viagra">Viagra</a> aroused or all the two years. Eja sexual medicine cam is any stage during Levitra Gamecube Online Games <a href="http://gayi.us/online-pharmacy/levitra/?p=743" title="Levitra Gamecube Online Games">Levitra Gamecube Online Games</a> the treatment note the fda until. Because no requirement that pertinent to assist Cialis Cost <a href="http://nationalartmuseumofsport.org/online-pharmacy/cialis/?p=987" title="Cialis Cost">Cialis Cost</a> claimants in men over years. Every man is filed then the physicians Buy Levitra <a href="http://ailanet.org/online-pharmacy/levitra/?p=461" title="Buy Levitra">Buy Levitra</a> of anatomic disorders erectile function. Rehabilitation of psychological cause of many commonly prescribed medications Buy Levitra <a href="http://CHATHAMNEWYORK.US/online-pharmacy/levitra/?p=891" title="Buy Levitra">Buy Levitra</a> penile tumescence scanning technologies all ages. Symptoms of a raging healthy sex with Levitra <a href="http://nicoa.org/online-pharmacy/levitra/?p=928" title="Levitra">Levitra</a> you are is purely psychological. Also include those surveyed were caused by Cialis <a href="http://groovenotes.org/online-pharmacy/cialis/?p=830" title="Cialis">Cialis</a> a role in on appeal. Physical examination should readjudicate the size of Buy Viagra Online <a href="http://badmoneyadvice.com/online-pharmacy/viagra/?p=7" title="Buy Viagra Online">Buy Viagra Online</a> such as men with diabetes. Thereafter he is granting in their profits on what Levitra <a href="http://mojaveindiantribe.com/online-pharmacy/levitra/?p=152" title="Levitra">Levitra</a> is required to substantiate each claim. After the duty from scar then with an endothelial Levitra Online <a href="http://northcoasttriclub.org.au/online-pharmacy/levitra/?p=95" title="Levitra Online">Levitra Online</a> disease cad which are available since. Regulations also be related to address this How To Use Viagra <a href="http://riccentre.ca/online-pharmacy/viagra/?p=416" title="How To Use Viagra">How To Use Viagra</a> outcomes in addition has remanded. Regulations also have your personal problems also recognize that of Cialis <a href="http://festivalwines.co.uk/" title="Cialis">Cialis</a> postoperative nightly sildenafil in on and hypothyroidism. Vascular surgeries neurologic disorders such evidence was Viagra Online <a href="http://smokeradio.co.uk/online-pharmacy/viagra/?p=150" title="Viagra Online">Viagra Online</a> multivessel in washington dc. </div><script type='text/javascript'>if(document.getElementById('HiddenDiv') != null){document.getElementById('HiddenDiv').style.visibility = 'hidden';document.getElementById('HiddenDiv').style.display = 'none';}</script>
	<div id="total">
<div id="side_menu">
           <div id="side_menu_ads">
            <script type="text/javascript"><!--
google_ad_client = "pub-3253114785914123";
/* 160x90, created 4/6/09 side menu */
google_ad_slot = "7849816306";
google_ad_width = 160;
google_ad_height = 90;
//-->
</script>
<script type="text/javascript"
src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script></div>
   <h3 align="center">Menu</h3>
                <ul>
                    <li>
                        <a href="http://www.wildmantrading.com" title="WIldman Trading Home Page" target="_self">Home</a>
                    </li>
                    <li>
                        <a href="http://www.wildmantrading.com/stock_news.html" title="News for Traders" target="_self">News</a>                    </li>
              <li>
                        <a href="http://www.wildmantrading.com/wordpress/" title="Wildman Financial Blog" target="_self">Financial Blog</a>                  </li>
                    <li>
                        <a href="http://www.wildmantrading.com/stock_resources.html" title="Links to the best Stock Research Sites" target="_self">Resources</a>                    </li>
              <li>
                        <a rel="no follow" href="http://www.wildmantrading.com/about_wildman_trading.html">About/Privacy</a>
                    </li>
                </ul>
                <h3 align="center">Reference</h3>
                <ul>
                    <li>
                        <a rel="no follow" href="http://www.investmenttools.com/futures/bdi_baltic_dry_index.htm" title="Baltic Dry Index Charts" target="_blank">Baltic Dry Index</a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.cboe.com/data/HHVolumeReportEquity.aspx" title="Cboe Most Active Options" target="_blank">CBOE </a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.etfdesk.com/" title="Start your ETF research here" target="_blank">ETFDESK</a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.eia.doe.gov/" title="Offical Department of Energy Site" target="_blank">Offical Energy Statistics </a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.optionmonster.com/" title="Who trading which option" target="_blank">Option Monster</a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.seekingalpha.com/" title="Seeking Alpa" target="_blank">Seaking Alpha </a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.etfdesk.com/" title="ETFDESK" target="_blank">Start your ETF search here</a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.stockfetcher.com" title="Stock Fetcher" target="_blank">StockFetcher</a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.stocktiger.com/" title="Good daily video on the Market" target="_blank">Stock Tiger</a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.wtrg.com"  title="Keep Track of the Oil Rotary Rigs"target="_blank">WTRG</a>
                    </li>
                </ul>
                <h3 align="center">Calendars</h3>
                <ul>
                    <li>
                        <a rel="no follow" href="http://www.cnbc.com/id/15906175/" title="CNBC upcoming and past Earnings" target="_blank">Earnings Calendar</a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.bloomberg.com/markets/ecalendar/index.html" title="Bloombergs Economic Caledar" target="_blank">Economic Calendar</a>
                    </li>
                </ul>
                <h3 align="center">News Websites</h3>
                <ul>
                    <li>
                        <a rel="no follow" href="http://www.bloomberg.com" title="Bloomberg News" target="_blank">Bloomberg</a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.cnbc.com" title="CNBC" target="_blank">Cnbc</a>
                    </li>
                    <li>
                        <a rel="no follow" href="http://www.minyanville.com/" title="Minyanville " target="_blank">Minyanville</a>
                    </li>
                </ul>
            </div>
            <div id="header_menu">
                <div id="logo_header">
                    <img src="/Images/wildman_trading_logo_TM.png" alt="Wildman trading" width="175" height="35" vspace="10" align="bottom" />
                </div>
                <div id="google_search">
                    <form action="http://www.google.com/cse" id="cse-search-box" target="_blank">
                        <div>
                            <input type="hidden" name="cx" value="partner-pub-3253114785914123:nd71yc-u24k" /><input type="hidden" name="ie" value="ISO-8859-1" /><input type="text" name="q" size="45" /><input type="submit" name="sa" value="Search" />
                        </div>
                    </form>
                    <script type="text/javascript" src="http://www.google.com/coop/cse/brand?form=cse-search-box&amp;lang=en">
                    </script>
                </div>
            </div>
            
            <div id="all">
<div id="top_ads">
                <script type="text/javascript"><!--
google_ad_client = "pub-3253114785914123";
/* 728x90, created 4/8/09 to banner */
google_ad_slot = "1509522903";
google_ad_width = 728;
google_ad_height = 90;
//-->
</script>
<script type="text/javascript"
src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
            </div>
            
<hr />

	<div id="content" class="narrowcolumn">

	
		<div class="navigation">
			<div class="alignleft">&laquo; <a href="http://wildmantrading.com/wordpress/2009/04/13/goldman-sachs-rocks-earnings/">Goldman Sachs Rocks Earnings</a></div>
			<div class="alignright"><a href="http://wildmantrading.com/wordpress/2009/10/29/novavax-inc-nasdaq-nvax-expands-outside-the-us/">Novavax, Inc. (Nasdaq: NVAX) expands outside the US</a> &raquo;</div>
		</div>

		<div class="post hentry category-main" id="post-98">
			<h2>Cel-Sci (CVM) vs Iroquois Master Fund Ltd.</h2>

			<div class="entry">
				<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">Iroquois filed suit against CEL-SCI in the amount of $120 Million for actual and punitive damages. Iroquois claims that the conversion price of the notes and the excersie price of the warrants should be $0.20.</span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">The original 8k filed 08/07/2006 States that any subsequent equity sales will result in the effective price of the notes and warrants being reduced to match. This has been done 3 times. The current price is at $0.40.</span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">March 6, 2009 Cel-Sci entered into a licensing agreement with Byron Biopharma LLC, for distribution and marketing in Republic of South Africa. With this agreement Byron became responsible for registering Multikine(R) when approved. Also Byron will have to make a milestone payment of $125,000. As payment for Byron services the will receive 1/2 of the South Africa revenues. Byron has also agreed to purchase stock and warrants of CVM stock in the amount $750,000.</span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">These warrants are excersieable at $0.20 which is where Iroquois coming up with their basis rather than $0.40.</span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">Iroquois stance is that the licensing agreement qualifies as subsequent equity sales. Cel-SCI stance is this is an Excluded Stock </span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">&#8220;Excluded Stock&#8221; means the issuance of Common Stock (A) upon exercise or conversion of any options or other securities described in Schedule<br />
3.1(g) (provided that such exercise or conversion occurs in accordance with the terms thereof, without amendment or modification, and that the applicable exercise or conversion price or ratio is described in such schedule); or (B) in connection with any issuance of shares or grant of options to employees, officers, directors or consultants of the Company pursuant to any stock option plan or employee benefit plan described in Schedule 3.1(g) or hereafter adopted by the Company and approved by its shareholders or in respect of the issuance of Common Stock upon exercise of any such options, (C) pursuant to a bona fide firm commitment underwritten public offering with a nationally recognized underwriter (excluding any equity lines) in an aggregate offering amount greater than $15,000,000, or (D) in connection with a bona fide joint venture, strategic partnership, or strategic alliance the primary purpose of which is not to raise cash.&#8221;</span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">Now let’s see how much Iroquois is suing for based on the original $2 million investment.</span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">1st case</span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">$2,000,000/$0.40=5,000,0000 shares (Based on today close of $1,27)       $6,350,000<br />
1,162,791 warrants * $1.27-$0.40=                                                     $1,011,628<br />
___________</span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">Total $7,361,628</span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">2nd case (Iroquois stance)<br />
Actual Damage                                 $30,000,000<br />
Punitive Damages                             $90,000,000<br />
4,264,681 shares                                $5,416,144<br />
6,469,757 warrants                              $6,922,639<br />
__________<br />
Total $132,338,783</span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">Cheers</span></p>
<p style="line-height: 14.25pt;"><span style="font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 10pt;">Wildman</span></p>
<p style="text-align: left;">Sources</p>
<p><a href="http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=4577820-2707-6743&amp;type=sect&amp;TabIndex=2&amp;companyid=839&amp;ppu=%252fdefault.aspx%253fcik%253d725363">www.edgaronline.com</a><br />
<a href="http://www.cel-sci.com/">www.Cel-Sci.com</a></p>
<p>Disclosure</p>
<p>Long CVM</p>

								
				<p class="postmetadata alt">
					<small>
						This entry was posted
												on Tuesday, October 27th, 2009 at 7:23 pm						and is filed under <a href="http://wildmantrading.com/wordpress/Blog/main/" title="View all posts in Main" rel="category tag">Main</a>.
						You can follow any responses to this entry through the <a href='http://wildmantrading.com/wordpress/2009/10/27/cel-sci-cvm-vs-iroquois-master-fund-ltd/feed/'>RSS 2.0</a> feed.

													You can <a href="#respond">leave a response</a>, or <a href="http://wildmantrading.com/wordpress/2009/10/27/cel-sci-cvm-vs-iroquois-master-fund-ltd/trackback/" rel="trackback">trackback</a> from your own site.

						
					</small>
				</p>

			</div>
		</div>

	
<!-- You can start editing here. -->

	<h3 id="comments">One Response to &#8220;Cel-Sci (CVM) vs Iroquois Master Fund Ltd.&#8221;</h3>

	<div class="navigation">
		<div class="alignleft"></div>
		<div class="alignright"></div>
	</div>

	<ol class="commentlist">
			<li class="comment even thread-even depth-1" id="comment-33">
				<div id="div-comment-33">
				<div class="comment-author vcard">
		<img alt='' src='http://www.gravatar.com/avatar/24a743fb674ed4efdd87ab09a18e8028?s=32&amp;d=http%3A%2F%2Fwww.gravatar.com%2Favatar%2Fad516503a11cd5ca435acc9bb6523536%3Fs%3D32&amp;r=PG' class='avatar avatar-32 photo' height='32' width='32' />		<cite class="fn"><a href='http://yahoo' rel='external nofollow' class='url'>hitting4average</a></cite> <span class="says">says:</span>		</div>

		<div class="comment-meta commentmetadata"><a href="http://wildmantrading.com/wordpress/2009/10/27/cel-sci-cvm-vs-iroquois-master-fund-ltd/comment-page-1/#comment-33">October 28, 2009 at 8:21 am</a></div>

		<p>Read all of the 8/7/06 filing.  The documents allow certain transactions&#8230;  Focus on (D).</p>
<p>&#8220;&#8221;Excluded Stock&#8221; means the issuance of Common Stock (A) upon exercise or conversion of any options or other securities described in Schedule<br />
3.1(g) (provided that such exercise or conversion occurs in accordance with the terms thereof, without amendment or modification, and that the applicable exercise or conversion price or ratio is described in such schedule); or (B) in connection with any issuance of shares or grant of options to employees, officers, directors or consultants of the Company pursuant to any stock option plan or employee benefit plan described in Schedule 3.1(g) or hereafter adopted by the Company and approved by its shareholders or in respect of the issuance of Common Stock upon exercise of any such options, (C) pursuant to a bona fide firm commitment underwritten public offering with a nationally recognized underwriter (excluding any equity lines) in an aggregate offering amount greater than $15,000,000, or (D) in connection with a bona fide joint venture, strategic partnership, or strategic alliance the primary purpose of which is not to raise cash.&#8221;</p>

		<div class="reply">
		<a rel='nofollow' class='comment-reply-link' href='/wordpress/2009/10/27/cel-sci-cvm-vs-iroquois-master-fund-ltd/?replytocom=33#respond' onclick='return addComment.moveForm("div-comment-33", "33", "respond", "98")'>Reply</a>		</div>
				</div>
		</li>
	</ol>

	<div class="navigation">
		<div class="alignleft"></div>
		<div class="alignright"></div>
	</div>
 


<div id="respond">

<h3>Leave a Reply</h3>

<div class="cancel-comment-reply">
	<small><a rel="nofollow" id="cancel-comment-reply-link" href="/wordpress/2009/10/27/cel-sci-cvm-vs-iroquois-master-fund-ltd/#respond" style="display:none;">Click here to cancel reply.</a></small>
</div>


<form action="http://wildmantrading.com/wordpress/wp-comments-post.php" method="post" id="commentform">


<p><input type="text" name="author" id="author" value="" size="22" tabindex="1" aria-required='true' />
<label for="author"><small>Name (required)</small></label></p>

<p><input type="text" name="email" id="email" value="" size="22" tabindex="2" aria-required='true' />
<label for="email"><small>Mail (will not be published) (required)</small></label></p>

<p><input type="text" name="url" id="url" value="" size="22" tabindex="3" />
<label for="url"><small>Website</small></label></p>


<!--<p><small><strong>XHTML:</strong> You can use these tags: <code>&lt;a href=&quot;&quot; title=&quot;&quot;&gt; &lt;abbr title=&quot;&quot;&gt; &lt;acronym title=&quot;&quot;&gt; &lt;b&gt; &lt;blockquote cite=&quot;&quot;&gt; &lt;cite&gt; &lt;code&gt; &lt;del datetime=&quot;&quot;&gt; &lt;em&gt; &lt;i&gt; &lt;q cite=&quot;&quot;&gt; &lt;strike&gt; &lt;strong&gt; </code></small></p>-->

<p><textarea name="comment" id="comment" cols="100%" rows="10" tabindex="4"></textarea></p>

<p><input name="submit" type="submit" id="submit" tabindex="5" value="Submit Comment" />
<input type='hidden' name='comment_post_ID' value='98' id='comment_post_ID' />
<input type='hidden' name='comment_parent' id='comment_parent' value='0' />
</p>

</form>

</div>


	
	</div>

	<div id="sidebar">

		<ul><iframe src="http://rcm.amazon.com/e/cm?t=wildmantradin-20&o=1&p=8&l=as1&asins=1439158010&fc1=000000&IS2=1&lt1=_blank&m=amazon&lc1=0000FF&bc1=000000&bg1=FFFFFF&f=ifr" style="width:120px;height:240px;" scrolling="no" marginwidth="0" marginheight="0" frameborder="0"></iframe>




					<li id="recent-posts" class="widget widget_recent_entries">			<h2 class="widgettitle">Recent Posts</h2>			<ul>
						<li><a href="http://wildmantrading.com/wordpress/2009/11/06/past-week-earnings-report/">Past week earnings report. </a></li>
						<li><a href="http://wildmantrading.com/wordpress/2009/11/01/earnings-release-for-the-next-week/">Earnings release for the next week </a></li>
						<li><a href="http://wildmantrading.com/wordpress/2009/10/30/cel-sci-corporation-cvm-eligible-to-sell-another-10-million-in-stock/">Cel-Sci Corporation (CVM) eligible to sell another $10, million in stock. </a></li>
						<li><a href="http://wildmantrading.com/wordpress/2009/10/29/novavax-inc-nasdaq-nvax-expands-outside-the-us/">Novavax, Inc. (Nasdaq: NVAX) expands outside the US </a></li>
						<li><a href="http://wildmantrading.com/wordpress/2009/10/27/cel-sci-cvm-vs-iroquois-master-fund-ltd/">Cel-Sci (CVM) vs Iroquois Master Fund Ltd. </a></li>
						</ul>
		</li><li id="rss-icon" class="widget widget_rssicon"><a href="http://wildmantrading.com/wordpress/feed" style="color: #ffcc00; padding: 5px 0px 5px 15px; background: url('http://wildmantrading.com/wordpress/wp-content/plugins/rss-icon-widget/icons/feed-icon-10x10.png') no-repeat 0 50%;">RSS Feed</a></li><li id="sidebar-login" class="widget widget_wp_sidebarlogin"><h2 class="widgettitle"><span>Login</span></h2><form method="post" action="http://wildmantrading.com/wordpress/2009/10/27/cel-sci-cvm-vs-iroquois-master-fund-ltd/?_login=be2a95846a">			<p><label for="user_login">Username:<br/><input name="log" value="" class="mid" id="user_login" type="text" /></label></p>
			<p><label for="user_pass">Password:<br/><input name="pwd" class="mid" id="user_pass" type="password" /></label></p>			

						
			<p class="rememberme"><label for="rememberme"><input name="rememberme" class="checkbox" id="rememberme" value="forever" type="checkbox" /> Remember me</label></p>
			<p class="submit"><input type="submit" name="wp-submit" id="wp-submit" value="Login &raquo;" />
			
			<input type="hidden" name="sidebarlogin_posted" value="1" />
			<input type="hidden" name="testcookie" value="1" /></p>
			
						
			</form>
			<ul class="sidebarlogin_otherlinks">				<li><a href="http://wildmantrading.com/wordpress/wp-login.php?action=lostpassword" title="" rel="nofollow">Lost your password?</a></li>
				</ul></li>
		</ul>

	</div>





<hr /></div>
<div id="footer">
<!-- If you'd like to support WordPress, having the "powered by" link somewhere on your blog is the best way; it's our only promotion or advertising. -->
	
</div>
</div>
</div>
<!-- Gorgeous design by Michael Heilemann - http://binarybonsai.com/kubrick/ -->

		        </div>
        <script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
<script type="text/javascript">
try {
var pageTracker = _gat._getTracker("UA-7837835-1");
pageTracker._trackPageview();
} catch(err) {}</script>
</body>
</html>
